SARS-CoV-2 Evolution in Humans Enables Its Transmission to Nonhuman Primates
Molecular Biology and Evolution · 2025
DOI: 10.1093/molbev/msaf281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology and Evolution, 2025. Verfasst von Yu-Ting Chiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Cellular Biology, National Tsing Hua University, No. 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan R.O.C. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Zoonotic viruses frequently cross-species barriers, but the molecular processes enabling reverse zoonosis remain poorly defined. The COVID-19 pandemic provided an unprecedented opportunity to track SARS-CoV-2 evolution in humans and its capacity to infect nonhuman primates. Our earlier analyses of primate ACE2 sequences identified key substitutions that confer resistance to wild-type (WT) SARS-CoV-2 and are conserved in New World monkeys (NWMs), establishing a strong species barrier. Using pseudovirus assays with HeLa cells expressing New World monkey ACE2 (nwmACE2), we show that while WT and Alpha strains could not infect, later variants such as Delta, Omicron, and especially the XBB lineage (XBB.1.5, EG.5.1) acquired robust infectivity toward nwmACE2. More recent lineages (JN.1, LB.1, KP.3.1.1) displayed reduced but persistent cross-species infectivity. Molecular dynamics simulations and a combined mutation prioritization framework converged key receptor-binding domain residues (including N405, N417, R452, N477, K478, A484, P486, S490, R498, and Y501) as critical contributors of adaptation to NWM receptors. These mutations act synergistically to overcome ACE2 barriers in NWMs, correlating with documented natural infections in the field. Collectively, our findings demonstrate that human-driven viral evolution has progressively enhanced the potential of SARS-CoV-2 for cross-species transmission to nonhuman primates, underscoring the need for ongoing surveillance to mitigate future reverse zoonosis crises.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular and Cellular Biology, National Tsing Hua University, No. 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan R.O.C.
- Institute of Bioinformatics and Structural Biology, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan R.O.C.
- Biodiversity Research Center, Academia Sinica, 128 Academia Road, Sec. 2, Nankang, Taipei 11529, Taiwan R.O.C.
- Taoyuan Armed Forces General Hospital, No.168, Zhongxing Rd., Longtan Dist, Taoyuan City 325208, Taiwan R.O.C.
- Department of Ecology and Evolution, The University of Chicago, 1101 East 57th Street, Chicago, IL 60637, USA.
- School of Medicine, National Tsing Hua University, No. 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan R.O.C.
ORCID-Profile: Yu-Ting Chiu, Yu-Sung Huang, Max Yu-Chen Pan, Chih-Yao Chang, Chih-Chien Chiu, Hong Vinh Nguyen, Ting-Hui Lee, Yuh-Ju Sun, Wen-Hsiung Li, Lily Hui-Ching Wang
Zitieren
APA
Chiu, Y. T., Huang, Y. S., Pan, M. Y., Chang, C. Y., Chiu, C. C., Nguyen, H. V., Lee, T. H., Sun, Y. J., Li, W. H., & Wang, L. H. (2025). SARS-CoV-2 Evolution in Humans Enables Its Transmission to Nonhuman Primates. Molecular Biology and Evolution. https://doi.org/10.1093/molbev/msaf281
Vancouver
Chiu YT, Huang YS, Pan MY, Chang CY, Chiu CC, Nguyen HV, et al. SARS-CoV-2 Evolution in Humans Enables Its Transmission to Nonhuman Primates. Molecular Biology and Evolution. 2025. doi:10.1093/molbev/msaf281
BibTeX
@article{Chiu2025,
author = {Chiu, Yu-Ting and Huang, Yu-Sung and Pan, Max Yu-Chen and Chang, Chih-Yao and Chiu, Chih-Chien and Nguyen, Hong Vinh and Lee, Ting-Hui and Sun, Yuh-Ju and Li, Wen-Hsiung and Wang, Lily Hui-Ching},
title = {SARS-CoV-2 Evolution in Humans Enables Its Transmission to Nonhuman Primates},
journal = {Molecular Biology and Evolution},
year = {2025},
doi = {10.1093/molbev/msaf281}
}
EUVIMED